Lumbar disc herniation is among the most common spinal pathologies, with rapidly evolving treatment options. Disc in Focus is a series of peer-to-peer conversations between spine surgeons engaged in exploring and advancing these treatments, in hopes of bu
What does the future look like for surgeons who want to preserve the disc? Welcome back Prof. Thomé of the University of Innsbruck and Dr. Nunley of the Spine Center of Louisiana, and welcome Prof. Härtl of the Weill Cornell Brain and Spine Center in New York, a leader in biologics research for disc regeneration. LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Prof. Härtl's bio: https://www.linkedin.com/in/roger-h%C3%A4rtl-92955b185/ Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley Prof. Thomé's bio: https://www.linkedin.com/in/claudius-thom%C3%A9-6974b978/?originalSubdomain=at For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
What are surgeons doing now to preserve the disc, and what technologies are they using? Welcome back Prof. Thomé of the University of Innsbruck and Dr. Nunley of the Spine Center of Louisiana, and welcome Prof. Härtl of the Weill Cornell Brain and Spine Center in New York, a leader in biologics research for disc regeneration. LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Prof. Härtl's bio: https://www.linkedin.com/in/roger-h%C3%A4rtl-92955b185/ Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley Prof. Thomé's bio: https://www.linkedin.com/in/claudius-thom%C3%A9-6974b978/?originalSubdomain=at For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
Why is preserving the disc important, and what is the historical context in spine surgery? Welcome back Prof. Thomé of the University of Innsbruck and Dr. Nunley of the Spine Center of Louisiana, and welcome Prof. Härtl of the Weill Cornell Brain and Spine Center in New York, a leader in biologics research for disc regeneration. LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Prof. Härtl's bio: https://www.linkedin.com/in/roger-h%C3%A4rtl-92955b185/ Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley Prof. Thomé's bio: https://www.linkedin.com/in/claudius-thom%C3%A9-6974b978/?originalSubdomain=at For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
It's the final installment in this interview series - and we're talking follow-up. Join Dr. Pierce Nunley & Dr. Adisa Kuršumović to learn about a real-world registry. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Dr. Kuršumović' bio: https://blog.barricaid.com/blog/author/adisa-kursumovic Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
What can we learn from a surgeon who's performed over 200 Barricaid implantations? Join Dr. Pierce Nunley & Dr. Adisa Kuršumović for lessons and tips from the operating room. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Dr. Kuršumović' bio: https://blog.barricaid.com/blog/author/adisa-kursumovic Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley
What can we learn from a surgeon who has implanted over 200 Barricaids? Join Dr. Pierce Nunley & Dr. Adisa Kuršumović for a conversation on surgical steps for Barricaid implantation. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Dr. Kuršumović' bio: https://blog.barricaid.com/blog/author/adisa-kursumovic Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
Who is annular closure for, and when would you use it? Join Dr. Pierce Nunley & Dr. Adisa Kuršumović for a conversation on patient selection for Barricaid. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ Dr. Kuršumović' bio: https://blog.barricaid.com/blog/author/adisa-kursumovic Dr. Nunley's bio: https://blog.barricaid.com/blog/author/pierce-nunley For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
And finally, what possibilities and combinatorial treatments might annular closure open up for the future of surgery? Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on identifying and treating an unmet clinical need in a subpopulation of discectomy patients. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
How can surgeons avoid complicating an otherwise-simple procedure? Prof. Thomè offers expertise to flatten the learning curve. Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on identifying and treating an unmet clinical need in a subpopulation of discectomy patients. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
What is bone-anchored annular closure, what makes it different, and how does it work? Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on identifying and treating an unmet clinical need in a subpopulation of discectomy patients. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
What can we learn from the results? Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on the 554-patient pivotal study of discectomy patients with large annular defects. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
Which patients are at highest risk for reherniation? Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on identifying and treating an unmet clinical need in a subpopulation of discectomy patients. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions
Why close the hole following discectomy? Join Dr. Pierce Nunley, Director of the Spine Institute of Louisiana, as he interviews Prof. Claudius Thomè of the University of Innsbruck, Austria on identifying and treating an unmet clinical need in a subpopulation of discectomy patients. For video interviews: www.youtube.com/barricaid LinkedIn: https://www.linkedin.com/company/intrinsic-therapeutics/ For full Barricaid indications and benefit-risk information: www.barricaid.com/instructions